BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Applied Nanoscience Announces Key International Patent Development Further Expanding Intellectual Property Portfolio


6/2/2009 11:12:29 AM

CARLSBAD, CA--(Marketwire - June 02, 2009) -

Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today announced it has received formal notification for the issuance of four patents in Mexico for its broad IP platform encompassing "Filtering Devices Incorporating Nanoparticles." The patent coverage will include three main methods of associating nanoparticles with filter media: (1) having pellets of nanoparticles located adjacent to the filter media, (2) coating the filter media with a powder of nanoparticles, and (3) impregnating the nanoparticles into the filter media.

The Company already holds this broad patented protection in Australia, India, New Zealand, Russia, Singapore and Taiwan and has active applications encompassing 40+ countries around the world including the United States. "This expansion of protected intellectual property continues to increase the value of our overall portfolio and should build shareholder value. The strategic advantage of this specific coverage as it relates to potential licensee partnerships and nanotechnology enhanced filtration product manufacturing is quite promising," said Thomas K. Allen, President and CEO, ANI.

In addition, ANI continues to focus on U.S. patent efforts tied to its NanoFense™ formulation, a proprietary antimicrobial nanoparticle filter "coating." This technology development effort complements and bolsters all of the issued patent coverage for many air filtration applications in some of the most heavily populated regions of the world. "Our focused two-prong approach to building a valuable and synergistic IP portfolio will directly benefit potential licensees in all air filtration applications," stated Mr. Allen.

About ANI

ANI is a marketer and developer of innovative nanotechnology-based air filtration products specifically targeted to eradicate bacteria, virus and fungi and is the owner of NEFT™ (Nanoparticle - Enhanced - Filtration - Technology), a broad platform with significant application potential in consumer and industrial market segments geared to reducing the transmission of infectious pathogens.

For further information about Applied Nanoscience Inc., please visit: www.appliednanoscience.com

Safe Harbor Statement

This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. ANI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.


Contact:
Philippe Niemetz
800-477-7570
212-344-6464
p.niemetz@panconsultants.com
Investor Relations
PAN Consultants Ltd.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES